← FDA Medical Device Classifications

System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection

PHP · Class III — High Risk (PMA approval required, life-sustaining) · Unknown

Classification

FDA Product Code
PHP
Device class
Class III — High Risk (PMA approval required, life-sustaining)
Regulation
Review panel
PA
Medical specialty
Unknown
Submission type
2
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N

Definition

The colorectal neoplasia DNA methylation and hemoglobin detection system is a qualitative, non-invasive device used to screen for the detection of methylation of specific DNA markers associated with colorectal cancer and for the presence of occult hemoglobin in human specimens, including stool, blood, urine, and buccal swabs. It is intended as an aid in the detection of colorectal cancer or advanced adenomas in conjunction with diagnostic colonoscopy. It is indicated for use in adults 50 years or older, who are typical average-risk candidates for colorectal cancer (CRC) screening.

Market data

Cleared 510(k) submissions
0
Registered establishments
11

Source

Authoritative
FDA Device Classification database
Machine
JSON-LD · Markdown